Akebia Therapeutics (NASDAQ:AKBA) Upgraded by Piper Sandler to Overweight

Piper Sandler upgraded shares of Akebia Therapeutics (NASDAQ:AKBA – Get Rating) from a neutral rating to an overweight rating in a research note released on Wednesday, The Fly reports. A number of other brokerages have also issued reports on AKBA. StockNews.com lowered Akebia Therapeutics from a buy rating to a hold rating in a research […]

Related Keywords

Michel Dahan ,Steven Keith Burke ,Piper Sandler ,Metlife Investment Management ,Hightower Advisors ,Securities Exchange Commission ,Jpmorgan Chase Co ,Akebia Therapeutics Inc ,Akebia Therapeutics Company Profile ,Mirabella Financial Services ,Icon Wealth Partners ,Akebia Therapeutics ,Get Rating ,Keith Burke ,Exchange Commission ,Wealth Partners ,Financial Services ,Tower Advisors ,Life Investment Management ,Akebia Therapeutics Daily ,Nasdaq Akba ,Nakba ,Medical ,Upgrade ,